Dividends
Picture of New York

Haleon

Haleon plc (FTSE 100: HLN) is listed on the London Stock Exchange, it is a British multinational consumer healthcare company and a global leader in over the counter medicines.

Haleon was spun out of GSK and established on the 18th July 2022, it is the largest consumer healthcare business in the world.

The business is owned by GSK (13%) & Pfizer (32%) and the rest making up institutional funds and private investors.

Haleon’s purpose is to “improve the everyday health of everyone, everywhere”.

The company’s products are divided into 5 categories:

  1. Pain Relief
  2. Respiratory Health
  3. Digestive Health
  4. Oral Health
  5. Vitamins, minerals & supplements (VMS)

Haleon Brands

There are 5 power categories, then within each, there are local strategic brands.

  1. Pain Relief – Advil, Excedrin, Fenbid, Panadol, Voltaren,
  2. Respiratory Health – Contac, Flonase, Otrivin, Theraflu.
  3. Digestive Health – Eno, Fenistil, Nicolette, Nexium, Tums.
  4. Oral Health – Aquafresh, biotene, Parodontax, Polident, Sensodyne.
  5. Vitamins, minerals & supplements (VMS) – Caltrate, Centrum, Emergen-C

For further brand information click here to go straight to their website brands page

Following the spin out from GSK the business was carrying quite an amount of debt, so in the early stages the business did not pay or distribute any dividends.

Haleon’s initial intention to pay down debt has been well executed enabling the business to start distributing bi-annual dividends.

At the proposed business spin-out I was entitled to be included in the newly formed Haleon shares through holding my original 100 GSK shares.

Each shareholder would stand to gain one share of HLN for every held GSK share.

The reason I opted for the GSK share split was after reading and digesting all the information about the new business, only by understanding where and how it would be positioned on the global stage did I proceed.

I perceived Haleon plc to be well positioned in the future healthcare space.

Being aware of its current brands, size, together with its ability to build on existing and add new brands and products, I foresee Haleon being a popular dividend stock in portfolios of the future.

Haleon Dividends

As Haleon is a newly spun out business the dividend history is somewhat limited to just two & a half years:

2024 £0.02 pence

2023 £0.06 pence

2022 £0.0.24 pence

Projections for the final year end distribution of a dividend will be announced early in 2025, subject to financials, debt obligations and repayments.

An interim dividend of £0.02 pence per share paid on 19/09/24 (Ex-dividend 15/08/24)

I look forward to seeing Haleon growing the dividends subject to the debt reducing and that is, providing sales continue to grow.

P/E: 22.72 (25/09/24)

Dividend Yield: 1.53% (25/09/24)

Total income received to date is just £10.40

Further dividend analysis can be viewed in the file below:

Alternatively, click on the link here to see how its affects the total 2024 income

HLN

Website Disclaimer:

Please remember that all investments can rise and fall in value, therefore you may get back less then you originally invested.

This website or webpage is not a suggestion to purchase or invest in any stocks / equities and is presented purely for research analysis.

Should you be unsure of any investment whether it be purchasing shares or equities directly, funds or investment trackers, you should seek independent financial advice from a qualified financial advisor.

All logos and Trademarks are the property of the company covered in this article. We only use logos/pictures to assist investors identify the Brand/s and encompassing products.